Pharmacy EBITDA explained: normalization, add-backs and what buyers pay for it

A pharmacy’s EBITDA is its earnings before interest, taxes, depreciation and amortization. Buyers and lenders do not price the figure on the financial statements; they price normalized EBITDA, which is reported EBITDA plus the owner’s compensation above a market manager salary, personal expenses run through the business and genuine one-time costs, less anything a new owner would have to pay that the current owner does not. Canadian community pharmacies are valued at a multiple of that number, most selling for 4x to 6x (see the province by province baselines), plus inventory at cost, so every properly documented $10,000 of add-backs is worth roughly $40,000 to $60,000 of price. This guide explains which adjustments are accepted, which are rejected, and how to document them.

The financial statements your accountant prepares each year tell one story. The normalized financials that pharmacy buyers want to see tell a very different story.

If you are planning to sell your independent pharmacy in Canada, understanding pharmacy EBITDA normalization is not optional. It is the single most important financial exercise that determines your asking price, influences buyer interest, and affects how much financing banks will approve.

In our experience, many pharmacy owners leave money on the table because they do not properly normalize their earnings. They present raw financials that understate the true earning capacity of their business. Buyers see lower profitability and make lower offers. Or worse, they walk away entirely because the numbers do not support their financing needs.

This guide explains exactly how to normalize your pharmacy’s EBITDA before you list your pharmacy for sale, what adjustments are legitimate, how to document them properly, and what buyers and banks will actually accept.

Quick summary: what you will learn

• What EBITDA normalization means and why it matters for pharmacy sales
• The difference between normalized EBITDA and Seller’s Discretionary Earnings (SDE)
• Seven categories of legitimate add-backs for Canadian pharmacy valuations
• How to document adjustments so buyers and banks accept them
• Common normalization mistakes that hurt your sale price
• What banks will and will not accept in their EBITDA calculations

What EBITDA normalization actually means

EBITDA normalization is the process of adjusting your pharmacy’s reported earnings to reflect the maintainable operating earnings a new owner can expect to generate.

EBITDA is earnings before interest, taxes, depreciation and amortization. Normalization adjusts expenses and income that actually ran through your income statement. It is not a cash flow figure: normalized EBITDA is before income taxes, capital spending and changes in working capital, which buyers and lenders look at separately.

Your current financial statements include many expenses that are specific to you as the current owner. Some are discretionary personal choices. Others are one-time events that will not repeat. Many reflect your particular compensation structure or how you have chosen to run the business.

A buyer does not care what you chose to pay yourself. They care what the business will generate for them after paying a fair market wage to operate the pharmacy.

Normalization removes or adjusts these owner-specific and non-recurring items to calculate maintainable EBITDA. This is the EBITDA figure that:

• Represents sustainable, ongoing profitability
• Can be consistently achieved by a competent new owner
• Forms the basis for your pharmacy’s valuation
• Determines how much financing buyers can secure

Think of it this way: your accountant prepares statements for tax and financial reporting. Normalized statements answer a different question: what can a buyer expect this business to earn on an ongoing basis? The two can produce very different numbers. A defensible normalization supports your value; an inflated one gets taken apart in due diligence.

Normalized EBITDA vs Seller’s Discretionary Earnings (SDE)

Before we dive into specific add-backs, you need to understand two related but different concepts that pharmacy buyers use.

Normalized EBITDA is your operating profit after paying a market wage for every role, including the pharmacist manager role you fill today, but before interest, taxes, depreciation, and amortization. It shows what the business earns whether or not the new owner works in it.

Seller’s Discretionary Earnings (SDE) starts from normalized EBITDA and adds back one owner’s market compensation (the salary and benefits for the role the owner fills). It shows what one owner operator earns before paying themself. SDE is used when the buyer plans to work as the primary pharmacist. Dividends and other owner distributions are not expenses, never reduced EBITDA, and are not added back in either measure.

For most independent pharmacy sales in Canada, both metrics matter:

• Corporate buyers or investors use normalized EBITDA (they will hire a manager)
• Pharmacist buyers who will work in the pharmacy use SDE
• Banks often want to see both to understand different buyer scenarios

Example. Your pharmacy shows:

Now normalize (all figures illustrative):

Normalized EBITDA still deducts the $120,000 market salary for the pharmacist manager role. For the SDE calculation, add that one owner’s compensation back:

(Check: reported EBITDA of $230,000 plus the full $150,000 owner salary plus $25,000 of personal spending also gives $405,000.)

Illustratively, a corporate buyer might value your pharmacy at 5x normalized EBITDA, or $1,425,000. That is the value of the operating business (equipment, leaseholds, patient files and goodwill), with inventory at cost added separately. In our experience, buyers who price on SDE use lower multiples, often in the 2.5x to 3x range, which here gives $1,012,500 to $1,215,000. Understanding both helps you price competitively for different buyer types.

The seven categories of legitimate add-backs

Canadian pharmacy valuations recognize seven main categories of normalization adjustments. Most are add backs, but rent normalization and extraordinary income can reduce EBITDA. Every adjustment must relate to an expense or income item that actually ran through the income statement for the period you are presenting. Let’s examine each in detail.

1. Owner compensation adjustments

This is typically the largest normalization adjustment for independent pharmacies.

What to add back:

• The difference between the salary you pay yourself and what a market rate replacement would cost
• Bonuses paid to you as salary (and expensed) beyond reasonable compensation
• Benefits you receive that exceed standard employee benefits
• Retirement contributions beyond typical employer matches

Dividends and other owner distributions are not expenses. They are paid out of after tax profit, never reduced EBITDA, and are not add backs. The adjustment is your salary, bonus and benefits compared with a market wage.

Example (illustrative): You pay yourself a $180,000 salary as owner pharmacist manager. Suppose a competent pharmacist manager in your market earns $115,000 to $125,000. You can add back $55,000 to $65,000 as excess owner compensation.

Documentation required: Salary surveys from your provincial pharmacy association, job postings for similar roles, or published pharmacist compensation data.

Important: You cannot add back your entire owner salary if you work full-time in the pharmacy. You can only add back the amount above market rate. Buyers need someone to fill your role.

2. Family member wages

Many independent pharmacy owners employ family members. These wages may be above market rate for the actual work performed, or the family member may not be essential to operations.

What to add back:

• Wages paid to family members who do not work in the business
• Amounts paid above market rate for the actual duties performed
• Salaries for family members whose roles can be eliminated or absorbed

Example: Your spouse handles bookkeeping 10 hours per week and receives $45,000 annually. A part-time bookkeeper costs $18,000. Add back $27,000.

Documentation required: Job descriptions, time records, and comparable wage data for similar roles.

Caution: If your family member performs essential work (like a spouse who is the only other pharmacist), you cannot add back their entire salary unless the buyer confirms they do not need that position filled.

3. Personal and discretionary expenses

Some owners have personal or mixed use costs running through the business. For valuation, these expenses reduce reported EBITDA but will not continue under new ownership, so they are added back. Tax treatment is a separate question: personal costs are generally not deductible business expenses and can be a taxable benefit to a shareholder. If any of these were deducted on past returns, talk to your accountant, because a buyer’s due diligence may raise the same question.

Common personal expenses to add back:

• Personal vehicle costs (if business use is minimal)
• Personal mobile phone and internet at home
• Meals and entertainment beyond reasonable business purposes
• The personal portion of conference travel
• Country club or gym memberships
• Professional development far exceeding industry norms

Example: Your financials show $22,000 in vehicle expenses, but your pharmacy has a delivery vehicle that costs $8,000 and your personal vehicle use is $14,000. Add back $14,000.

Documentation required: A detailed expense breakdown showing business versus personal use, credit card statements, and receipts.

Warning: Be conservative and honest. Buyers will scrutinize these during due diligence. Aggressive claims hurt credibility.

4. One-time and non-recurring expenses

Expenses that ran through the income statement, happened once, and will not repeat under normal operations can be added back.

Examples of legitimate one-time add-backs:

• Legal fees for a specific dispute or one-time contract negotiation
• A major repair that was expensed (not capitalized) and will not recur, such as emergency repairs after a flood
• Costs related to the sale itself, where the pharmacy expensed them (see category 7)
• Unusually high bad debt write-offs from a specific event
• The expensed portion of a one time software conversion (data migration, training); hardware is usually capitalized and is not an add back
• Relocation expenses if you temporarily moved locations
• Severance payments to terminated employees
• Insurance claim deductibles from a one-time loss

Example (illustrative): Last year a burst pipe damaged the dispensary. The $12,000 of emergency repairs and cleanup not covered by insurance was booked to repairs and maintenance expense, and nothing like it happened in the prior years. Add back $12,000. At an illustrative 5x multiple, that supports about $60,000 of value.

Documentation required: Invoices clearly showing the one-time nature of the expense, the general ledger entry showing it was expensed, plus explanatory notes in your normalization schedule. Buyers will check the general ledger.

Important distinction: Regular maintenance and repairs are ongoing operating expenses. You cannot add these back. Capital spending is not an add back either. If you spent $45,000 renovating the dispensary and your accountant capitalized it (recorded it as leasehold improvements on the balance sheet), it never reduced EBITDA, and its depreciation is already excluded by definition. Adding it back would overstate normalized EBITDA by $45,000, or about $225,000 of value at 5x. Buyers and lenders look at capital spending separately, as a cash need, when they work out cash available for debt service.

5. Rent normalization

If you own the building your pharmacy occupies and rent it to yourself through a separate company, the rent you charge affects EBITDA.

When to normalize rent:

• If you charge below-market rent to increase business EBITDA (knowing you receive the rent in another entity)
• If you charge above-market rent to shift income to a different tax structure

How to normalize: adjust EBITDA to reflect fair market rent for comparable commercial space in your area.

Example 1 (below market): You charge your pharmacy $2,000 per month ($24,000 per year) but comparable space rents for $4,500 per month ($54,000 per year). You must reduce EBITDA by $30,000 to show realistic costs.

Example 2 (above market): You charge $8,000 per month ($96,000 per year) but market rent is $5,000 per month ($60,000 per year). Add back $36,000 to EBITDA.

Documentation required: Commercial lease comparables (from real estate agents), property tax and operating cost analysis, and an independent appraisal of fair market rent.

Critical note: Most buyers will not purchase your building, so showing realistic rent is essential. If rent is significantly below market and the landlord (you) is selling, the buyer may face a sharp rent increase or need to relocate.

6. Extraordinary income adjustments

Just as you add back unusual expenses, you must remove unusual income that will not continue.

Examples:

• One-time manufacturer signing bonuses
• Government COVID-19 subsidies or emergency payments
• Insurance proceeds from a casualty loss
• Sale of used equipment above book value
• Discontinued service lines with temporary high revenue

Example: During COVID-19, your pharmacy received $35,000 in government wage subsidies. This will not recur. Subtract $35,000 from EBITDA.

Why this matters: Overstating ongoing income leads buyers to overvalue the pharmacy, which falls apart during due diligence and destroys trust.

7. Professional fees related to the sale

Sale related fees that the pharmacy actually expensed in the period you are presenting can be added back, since they are one-time costs. Fees paid personally by the shareholder, or that your accountant treats as a cost of selling your shares, never reduced pharmacy EBITDA and are not add backs. Check the general ledger so nothing is counted twice.

What may qualify, if the pharmacy expensed it:

• Broker commission and fees
• Legal fees for the sale transaction
• Accounting fees for preparing normalized financial statements
• Business valuation or appraisal costs
• Due diligence costs (environmental assessments if required)

Example (illustrative): In the most recent year your pharmacy paid $12,000 for a business valuation and $8,000 in legal fees to prepare for a sale, both booked as professional fees. Add back $20,000 in that year. A broker commission paid out of the sale proceeds at closing never ran through your historical income statement, so there is nothing to add back for it.

Timing note: Add each fee back only in the year it was actually expensed. If you are presenting three years of historical EBITDA, that may be one year or several, depending on when the costs were booked.

How to document your adjustments properly

Having legitimate add-backs is not enough. You must document them so buyers and their advisors accept them without suspicion.

Create a normalization schedule in a clear spreadsheet format, listing each adjustment, the amount for each of the three years, and a short explanation with references to supporting documents.

Best practices for documentation:

• Provide a written explanation for every adjustment over $5,000
• Attach supporting documents (invoices, comparables, surveys)
• Be consistent across all three years
• Use conservative estimates when ranges exist
• Highlight adjustments in your financial statement notes
• Have your accountant review and sign off on the normalization schedule

Buyers who see well-documented adjustments gain confidence. Buyers who see vague or unsupported claims become skeptical and reduce offers.

What banks will and will not accept

Here is the reality: even a well supported normalization will be tested again by the buyer’s lender, and lenders are usually more conservative than sellers.

Banks perform their own EBITDA normalization for lending purposes. They calculate bank-adjusted EBITDA, then work down to cash available for debt service (typically deducting income taxes and required maintenance capital spending, and sometimes owner draws above a market salary). That figure, compared with the annual loan payments, drives how much they will lend. Our guide to how Canadian banks evaluate pharmacy financing covers the lending side in depth.

Add-backs banks typically accept, in our experience (each lender decides case by case):

• Owner compensation above market (with solid comparables)
• Well-documented personal expenses (with receipts)
• Clearly one-time expenses that were expensed through the income statement (one time legal fees, an expensed emergency repair, and similar)
• Rent adjustments (with independent market data)

Add-backs banks often reject or discount:

• Manufacturer rebates or professional allowances: If a significant portion of your profit comes from rebates, banks may discount or exclude this income unless you have long-term contracts guaranteeing it will continue
• Projected cost savings: “The new owner could reduce staff” or “I am overpaying for supplies” are speculative. Banks want historical facts
• Family member wages without documentation: If you cannot prove market rates, banks will not accept the adjustment
• Personal expenses without business justification: If your “business meals” look high for a pharmacy of your size, expect questions

Example of bank conservatism. Your broker shows normalized EBITDA of $375,000, including:

Bank-adjusted EBITDA: $375,000 minus $35,000 minus $22,000 = $318,000.

This lower number reduces the buyer’s cash available for debt service, Debt Service Coverage Ratio and maximum loan amount. If your asking price and the buyer’s financing were built around $375,000 of EBITDA, the $57,000 haircut creates a gap that can delay closing or force the buyer to bring more equity.

Lesson: align your normalization with what banks will accept to avoid financing delays that kill deals.

Practical steps to normalize your pharmacy’s EBITDA

1. Gather three complete years of financial statements (profit and loss, general ledger detail).
2. Start with net income and calculate reported EBITDA by adding back interest, income tax expense, depreciation, and amortization.
3. Review every expense line item over $5,000 annually and ask: “Is this expense necessary for a new owner to operate the pharmacy?”
4. Identify and quantify each adjustment category (owner salary to market, personal expenses, genuinely non recurring expensed costs, rent, family wages, one time income). Confirm in the general ledger that each item was expensed (or booked as income) in the year you adjust it.
5. Research market data to support your adjustments (salary surveys, rent comparables, industry benchmarks).
6. Create a detailed normalization schedule showing each adjustment with an explanation and supporting documentation.
7. Have your accountant review the schedule for accuracy and reasonableness.
8. Calculate both normalized EBITDA (for investor buyers) and SDE (for owner-operator buyers).
9. Prepare a one-page summary explaining your normalization approach and key adjustments.
10. Include the normalization schedule and supporting documents in the Confidential Information Memorandum (CIM) that goes to qualified buyers during the sales process.

Common normalization mistakes that hurt sale price

Mistake 1: Adding back essential operating expenses. Some owners try to add back expenses they simply do not like paying but that are necessary. Marketing, ongoing training, and reasonable professional development are operating costs, not discretionary.

Mistake 2: Inconsistent adjustments across years. If you add back $40,000 in personal expenses in Year 3 but only $8,000 in Years 1 and 2, buyers will question the inconsistency. Be consistent or explain changes clearly.

Mistake 3: Undocumented adjustments. Stating “I add back $55,000 in personal expenses” without receipts, logs, or detail creates immediate buyer skepticism and often results in those add-backs being rejected entirely.

Mistake 4: Overly aggressive add-backs. Claiming every possible adjustment to show maximum EBITDA usually backfires during due diligence. Buyers reduce offers or walk away when they find the normalized numbers were unrealistic.

Mistake 5: Ignoring negative adjustments. Normalization works both ways. If you had unusually high one-time income, you must remove it. If your rent is below market and will increase under new ownership, EBITDA must be reduced. Honest normalization builds trust.

Mistake 6: Not addressing rebate dependency. If a large share of your EBITDA (say 30%) comes from manufacturer rebates or allowances where provincial rules permit them, you must address sustainability. Banks and sophisticated buyers are likely to discount this income unless you can show it is contractual and ongoing.

Mistake 7: Normalizing too late. Start preparing normalized financials 12 to 24 months before listing. This gives you time to adjust operations, clean up expenses, and establish a pattern buyers will trust. Last-minute normalization looks opportunistic.

Conclusion: normalization is not optional

At the 4x to 6x normalized EBITDA multiples we typically see, each dollar of properly documented add-back can support roughly $4 to $6 of value.

Illustratively, if you can legitimately add back $50,000 through proper normalization and your pharmacy is valued at 5x normalized EBITDA, that is about $250,000 of additional value. Value is not the same as the final price or your net proceeds after debt, tax and fees, but for many owners it is a meaningful amount.

But normalization must be done correctly. Aggressive adjustments without documentation destroy buyer confidence and lead to lower offers, not higher ones. Conservative, well-supported adjustments build trust and justify premium pricing.

Work with your accountant and a pharmacy valuation specialist to prepare your normalized financials at least one year before you plan to list your pharmacy for sale. In our experience, proper preparation usually more than pays for itself.

If you are preparing to sell your pharmacy and need expert guidance on normalization and financial presentation, our team provides comprehensive valuation and sale preparation services. Contact us for a confidential consultation.